Diagnostics 2011: M&A surges, companion diagnostics accelerate, and early detection offers new prospects

Listen to Loic Kubitza, Pharma & Life Sciences Director, give a brief overview of PwC's Diagnostics 2011.

Loic Kubitza
Loic Kubitza